# Rappta Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rappta-therapeutics

- Industry: Biotechnology
- Headquarters: Helsinki, Finland
- Website: www.rappta-therapeutics.com
- Total disclosed funding: $11M
- Latest round: Series A (Oct 13, 2020)
- Investors on record: 4

## About

Founded in 2019 and based in Helsinki, Finland, Rappta Therapeutics Oy operates as a biopharmaceutical company that develops protein phosphatase 2A (PP2A), an anti-cancer drug used to reactivate the key tumor suppressor.

## Funding rounds

- Series A, Oct 13, 2020, $11M — Novartis Venture Fund, Novo Holdings, Advent Life Sciences, Business Finland

## Investors

- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series A
- Novo Holdings — Series A
- Advent Life Sciences (https://capitalatlas.ai/funds/advent-life-sciences) — Series A
- Business Finland — Series A